After cornering the market in anti-aging treatments, the people behind Botox injections are currently developing a similar product which is designed to thicken and improve eyelash growth. Botox producers Allergan are working on a product called Latisse, which should help eyelashes to grow longer and also give them more volume.
The main ingredient of Latisse, bimatoprost, was used to treat glaucoma and one of the side effects was that the eyelashes became noticeably thicker and longer over the course of the treatment. At the moment, the product is not available in the UK but more than 4 million women in America, India, and Canada currently use it to give their eyelashes a boost. Latisse is being tested by Britain’s Medicines and Healthcare Products Regulatory Agency, according to the Sunday Times Style magazine.
Research has shown that the active ingredient bimatoprost can double eyelash thickness, darken lashes by up to 18% and lengthen them by up to 25% in just eight weeks, with daily usage. Latisse, unlike Botox, is not injected; it is applied in a similar fashion to eyeliner but can only be obtained with a prescription.
Allergan’s website also lists some of the possible side effects, which include; ‘increased brown pigmentation of the coloured part of the eye which is likely permanent. Eyelid darkening may occur and may be reversible. Hair may grow on skin that Latisse frequently touches. Common side effects are itchy and red eyes.’